株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

腫瘍アブレーションの世界市場:成長、動向、および予測(2019年~2024年)

Tumor Ablation Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 391461
出版日 ページ情報 英文 113 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.67円で換算しております。
Back to Top
腫瘍アブレーションの世界市場:成長、動向、および予測(2019年~2024年) Tumor Ablation Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年09月01日 ページ情報: 英文 113 Pages
概要

世界の腫瘍アブレーション市場の成長を促進する要因には、癌の発生率の上昇、アブレーション装置の技術の進歩、および世界中の高齢者人口の増加などが挙げられます。

当レポートは世界の腫瘍アブレーション市場について調査しており、市場機会や動向、成長および阻害要因、技術・治療方法・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています

目次

第1章 イントロダクション

  • 調査成果
  • 調査の仮定
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 成長要因
  • 阻害要因
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競争

第5章 市場セグメント

  • 技術別
    • 高周波(Rf)
    • マイクロ波
    • 凍結
    • その他
  • 治療方法別
    • 外科
    • 腹腔鏡
    • 経皮
  • 用途別
    • 肝臓癌
    • 肺癌
    • 腎臓癌
    • 骨転移
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • AngioDynamics Inc.
    • Galil Medical, Inc.
    • NeuWave Medical, Inc.
    • Medtronic PLC
    • INTIO Inc.
    • SonaCare Medical, LLC
    • Misonix, Inc.
    • BVM Medical Limited
    • COMSOL Inc.
    • Boston Scientific Corporation

第7章 市場機会および将来動向

目次
Product Code: 52985

Market Overview

Certain factors that are propelling the growth of the market include rising incidence of cancer, technological advancements that are being done in the ablation devices, and a growing geriatric population across the globe.

Cancer has a social burden across all the major countries in the globe. According to the American Cancer Society, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States in the year 2019.

Approximately one in every six deaths is due to cancer globally. The low and middle-income countries contribute to around 70% of all cancer deaths. This is primarily due to poor treatment or lack of proper diagnosis for the disease in such countries.

High incidence of cancer across the globe is putting a high economic burden on the countries. Therefore, the need for better diagnostics and treatment for cancer has raised. Currently, efforts are being made by government organizations such as the World Health Organization, National Cancer Institute, Cancer Research UK, etc. to reduce the cancer incidence and create more awareness about prevention and cure of the disease.

Scope of the Report

Tumor ablation is an image-guided technique in which the cancer cells in the tumor are killed through the delivery of concentrated energy or chemicals; the energy or chemicals are delivered through probes/needles.

Key Market Trends

Radiofrequency Ablation (RFA) to Witness Highest CAGR in the Forecast Period

Radiofrequency ablation uses high-energy radio waves for treatment, in which a thin, needle-like probe is inserted into the tumor. A high-frequency current is then passed through the tip of the probe, which heats the tumor and destroys the cancer cells; this is a common treatment method for small tumors. This is the most widely used method of tumor ablation.

RFA is more effective in hepatocellular carcinoma (HCC), the most common primary liver neoplasia with a poor diagnosis. A study suggests that incidence of neoplasia can range from 500,000 to 1,000,000 cases, annually, which puts it at fifth rank worldwide. The disease is more prevalent in Asia due to hepatitis B virus (HBV) infection in the region.

The approach of RFA in destroying metastases of the liver is growing as less number of patients with HCC patients are candidates for surgery. Furthermore, the rate of relapse after curative surgery is high. Therefore, percutaneous techniques, like RFA, is considered. RFA is further expected to grow, as it is a minimally invasive, repeatable procedure with a low complication rate.

North America Dominates the Market

The growing investments of many key players in this market have grown significantly in the United States. In addition, the focus on the development of products with innovative features and greater effectiveness has increased in recent times. As a result, there has been a rise in R&D funds. The US government allocated funds of more than USD 5 billion to the National Cancer Institute (NCI) in 2016, an increase of more than 5.3% as compared to the previous year. Owing to the strict regulatory oversight, all the tumor ablation systems are replaced as per the replacement schedule stipulated by healthcare regulatory authorities, thus ensuring that the new sales of tumor ablation systems in the country are reasonably consistent.

The market growth in the region is supported by the rising prevalence of cancer. Moreover, the number of people with a higher risk for a variety of cancers (aging population) is increasing in the region. It has been estimated that 98 million American people will be aged 65 or more by the year 2060.

Therefore, growing investment by the companies and the rise in geriatric population are major factors that will continue to contribute to the market growth.

Competitive Landscape

The tumor ablation market is consolidated and consists of the few major players. Most of the companies that are dominating the market are based in the United States and other countries like Australia, Germany, Japan, etc. With technological advancements, it is believed that new companies will enter the market in the coming future with their novel techniques.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Cancer
    • 4.2.2 Technological Advancement in Ablation Devices
    • 4.2.3 Rise in Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Strict Regulatory Process
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Radiofrequency (Rf) Ablation
    • 5.1.2 Microwave Ablation
    • 5.1.3 Cryoablation
    • 5.1.4 Other Technologies
  • 5.2 By Mode of Treatment
    • 5.2.1 Surgical Ablation
    • 5.2.2 Laparoscopic Ablation
    • 5.2.3 Percutaneous Ablation
  • 5.3 By Application
    • 5.3.1 Liver Cancer
    • 5.3.2 Lung Cancer
    • 5.3.3 Kidney Cancer
    • 5.3.4 Bone Metastasis
    • 5.3.5 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AngioDynamics Inc.
    • 6.1.2 Galil Medical, Inc.
    • 6.1.3 NeuWave Medical, Inc.
    • 6.1.4 Medtronic PLC
    • 6.1.5 INTIO Inc.
    • 6.1.6 SonaCare Medical, LLC
    • 6.1.7 Misonix, Inc.
    • 6.1.8 BVM Medical Limited
    • 6.1.9 COMSOL Inc.
    • 6.1.10 Boston Scientific Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top